Gotham Asset Management LLC Purchases 7,410 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Gotham Asset Management LLC increased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 22.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,610 shares of the medical instruments supplier's stock after buying an additional 7,410 shares during the period. Gotham Asset Management LLC owned 0.17% of ICU Medical worth $6,301,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FORA Capital LLC purchased a new stake in ICU Medical during the fourth quarter valued at about $488,000. Deutsche Bank AG raised its position in ICU Medical by 41.1% during the fourth quarter. Deutsche Bank AG now owns 21,792 shares of the medical instruments supplier's stock valued at $3,381,000 after purchasing an additional 6,345 shares in the last quarter. Algert Global LLC raised its position in ICU Medical by 16.9% during the fourth quarter. Algert Global LLC now owns 6,370 shares of the medical instruments supplier's stock valued at $988,000 after purchasing an additional 920 shares in the last quarter. Freestone Grove Partners LP purchased a new stake in ICU Medical during the fourth quarter valued at about $368,000. Finally, Northern Trust Corp raised its position in ICU Medical by 11.1% during the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock valued at $62,431,000 after purchasing an additional 40,187 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Trading Up 0.6%

Shares of ICUI traded up $0.84 during trading hours on Friday, hitting $141.38. The company had a trading volume of 265,115 shares, compared to its average volume of 276,487. The firm has a market cap of $3.48 billion, a P/E ratio of -30.94 and a beta of 0.87. The stock's 50 day moving average price is $140.85 and its 200 day moving average price is $154.10. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 52-week low of $100.91 and a 52-week high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.49. The company had revenue of $599.49 million for the quarter, compared to analysts' expectations of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. ICU Medical's quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm earned $0.96 earnings per share. On average, research analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on ICUI. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Raymond James decreased their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. StockNews.com downgraded ICU Medical from a "buy" rating to a "hold" rating in a report on Saturday, May 10th. Finally, KeyCorp decreased their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $192.67.

Insider Buying and Selling

In other ICU Medical news, COO Christian B. Voigtlander sold 5,555 shares of ICU Medical stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $135.55, for a total transaction of $752,980.25. Following the sale, the chief operating officer now directly owns 2,389 shares of the company's stock, valued at approximately $323,828.95. The trade was a 69.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ben Sousa sold 2,000 shares of ICU Medical stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total value of $274,720.00. Following the sale, the insider now directly owns 479 shares in the company, valued at approximately $65,795.44. The trade was a 80.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,053 shares of company stock valued at $2,077,027 over the last ninety days. 1.50% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.